WuXi Vaccines Receives Brazil's ANVISA GMP Certification
Based on the commercial manufacturing agreement with Instituto Butantan and Fundação Butantan, WuXi Vaccines will provide end-to-end services including drug substance and drug product manufacturing and quality control.
WuXi Vaccines | 12/02/2026 | By News Bureau
WuXi Vaccines, Harbour BioMed in partnership for manufacturing facility
The 8,500-square-metre facility includes multiple 250L, 500L and 1000L single-use bioreactors as well as sterile drug-product manufacturing lines
<br />
WuXi Vaccines | 21/11/2022 | By Sudeep Soparkar | 836
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy